Table 3.

Management changes according to alternative etiology of left ventricular hypertrophy following a diagnosis change

	Optimized other cardiac risk factors	Decreased familial screening	Stopped empiric beta blocker	Undergoing further workup	No change
Concentric LVH, n=11 (%)	9 (82%)	3 (27%)	1 (9%)	1 (9%)	1 (9%)
Eccentric LVH, n=20 (%)	15 (75%)	7 (35%)	3 (15%)	1 (5%)	1 (5%)
Anatomic variants*, n=3 (%)	3 (100%)	3 (100%)	—	—	—
Amyloidosis, n=2 (%)	2 (100%)	1 (50%)	—	—	1 (50%)
Normal LV thickness, n=2 (%)	2 (100%)	1 (50%)	—	1 (50%)	—

^*3 anatomic variants were reviewed, including prior myocarditis, a sub-aortic membrane, and aortic stenosis.

LV = left ventricle; LVH = left ventricular hypertrophy.